Effect of adenoviral early genes and the host immune system on in vivo pancreatic gene transfer in the mouse

Pancreas

Volumn 15, Issue 3, 1997, Pages 236-245

  McClane, Steven J ^b   Hamilton, Thomas E ^a   DeMatteo, Ronald P ^b   Burke, Charlotte ^a   Râper, Steven E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenovirus; Gene transfer; Immune response; Mouse; Pancreas

Indexed keywords

BETA GALACTOSIDASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE TRANSFER; HOST; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; TRANSGENE; VIRUS GENE; VIRUS RECOMBINANT;

EID: 0030781362     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199710000-00004     Document Type: Article

References (40)

1. Andersen WF. Human gene therapy. Science 1992;256:808-13.
2. Miller AD. Human gene therapy cornes of age. Nature 1992;357:455-60.
3. Jaffe HA, Danel C, Longenecker G, et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet 1992:1:372-8.
4. Rosenfeld MA, Yoshimura K, Trapneli BC, et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992:68:143-55.
5. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1990:90:626-30.
6. Davidson BL, Alien ED, Kozarsky KF, Wilson JM, Roessler BJ. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet 1993:3:219-23.
7. Mastrangeli A, O'Connell B, Aladib W, Fox PC, Baum BJ, Crystal RG. Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am J Pliysiol 1994;266:G 1146-55.
8. Râper SE, DeMatteo RP. Development of a rat model for adenovirus-mediated in vivo gene transfer into the pancreas. Pancreas 1996;12(4):401-10.
9. Sener A, Herberg L, Malaisse W. FAD-linked glycerophosphate dehydrogenase deficiency in pancreatic islets of mice with hereditary diabetes. FEES Lett 1993;316:224-7.
10. Malaisse WJ. Perturbation of islet metabolism and insulin release. In: Efendic S, Ostenson C, Vranic M, eds. New concepts in the pathogenesis of NIDDM, Advances in experimental medicine and biology, Vol. 334. New York: Plenum, 1993:13-24.
11. Yang Y, Nunes F, Berencsi K, Furth E, Gonczol E, Wilson J. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994:91:4407-11.
12. Stratford-Perricaudet LD, Levrero M, Chasse J, Perricaudet M, Briand P. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther 1990; 1:241-56.
13. Yang Y, Li Q, Ertl H, Wilson J. Cellular and humoral immune responses to viral antigens create barriers to lung directed gene therapy with recombinant adenoviruses. J Virol 1995;69:2004-15.
14. Engelhardt JF, Yang Y, Stratford-Perricaudet LD, et al. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with El-deleted adenoviruses. Nature Genet 1993;4: 27-34.
15. Engelhardt JF, Ye X, Doranze B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994;91:6196-200.
16. Englehardt J, Litzky L, Wilson J. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum Gene Ther 1994;5:1217-29.
17. Wold WSM, Gooding LR. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 1991; 184:1.
18. Ginsberg HS, Lundholm-Beauchamp U, Horswood RL, et al. Role of early region 3 (E3) in pathogenesis of adenoviral disease. Proc Natl Acad Sci USA 1989;86:3823-7.
19. Bridge E, Medghalchi S, Sukithida U, Leesong M, Keiner G. Adenovirus early region 4 and viral DNA synthesis. Virology 1993; 193:794-801.
20. Gao G, Yang Y, Wilson J. Biology of adenovirus vectors with El and E4 deletions for liver-directed gene therapy. J Virol 1996;70 (12):8934-43.
21. Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in 2M, MHC class 1 proteins, and CD8+ T cells. Science 1990;248:1227-30.
22. Shinkai Y, Rathbun G, Lam K, et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992;68:855-67.
23. Logan J, Shenk T. Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection. Proc Natl Acad Sci USA 1984;81:3655-9.
24. Gilgenkrantz H, Duboc D, Juillard V, et al. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response. Hum Gene Ther 1995; 6:1265-74.
25. Mulbacher A, Belle AJD, Hla RT. The murine cellular immune response to adenovirus 5. Innmmol Cell Biol 1989;67:31-9. '
26. Routes JM, Bellgrau D, McGrory WJ, Bautista DS, Graham FL, Cook JL. Anti-adenovirus type 5 cytotoxic T lymphocytes: immunodominant epitopes are encoded by the Ela gene. J Virol 1991; 65:1450-7. '
27. DeMatteo RP, Markman JF, Kozarsky KF, Barker CF, Râper SE. Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion. Gene Ther 1996;3:4-12.
28. Yang Y, Hildegund CJE, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1994; 1:433-42.
29. Kevins JR. Mechanisms of activation of early viral transcription by the adenovirus Ela gene product. Cell 1981;26:213-20.
30. Imperiale MJ, Kao HT, Feldman LT, Kevins JR, Strickland S. Common control of the heat shock gene and early adenovirus genes: evidence for a cellular Ela-like activity. Mol Cell Biol 1984;4:867-74.
31. Dai Y, Schwanz EM, Gu D, Zhang W, Sarvetnick K, Verma IM. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995; 92:1401-5.
32. Yang Y, Jooss KU, Su Q, Ertl HCJ, Wilson JM. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther 1996;3:137-44.
33. DiSantagnese PA, Hubbard VS. The pancreas in cystic fibrosis. In: Taussig LM, éd. Cystic fibrosis. New York: Thieme-Stratton, 1984:230-1.
34. Snouwaert JN, Brigman KK, Latour AM, et al. An animal model for cystic fibrosis made by gene targeting. Science 1992;257: 1083-8.
35. Wilson JM. Vehicles for gene therapy. Nature (London) 1993;365: 691-2.
36. Povoski SP, Zhou \V, Longnecker DS, et al. Cholecystokinin receptor characterization and choIecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas. Oncol Res 1994;6:411-7.
37. Normal JG, Fink GW, Sexton C, et al. Transgenic animals demonstrate a role for the IL-1 receptor in regulating IL-1 beta gene expression at steady-state and during the systemic stress induced by acute pancreatitis. J Surg Res 1996;63:231-6.
38. Gu D, Molony L, Krahl T, et al. Treatment of IFN-gamma transgenic mice with anti-IFN-gamma reveals the remodeling capacity of the adult pancreas. Diabetes 1995;44:1161-4.
39. Froguel P, Zouali H, Vionnet N, et al. Familial hyperglycemia due to mutations in glucokinase. N Engl J Med 1993;328:697-702.
40. Efrat S, Leiser M, Wu YJ, et al. Ribozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion. Proc Natl AcadSciUSA 1994;91:2051-5.